Vaccine hesitancy survey in Natal, Brazil
Part of Infections clinical trials.
This study is a survey to understand how people feel about vaccines and what makes them hesitant. It is for adults living in certain neighborhoods in Natal, Brazil, or for healthcare workers there.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You live in one of these neighborhoods in Natal: Pajuçara, Felipe Camarão, Lagoa Azul, or Planalto.
- OR you are a healthcare professional who works in the city of Natal.
- You are willing to answer a short questionnaire about your thoughts on vaccines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks parents about their knowledge and opinions on vaccinating their children. It aims to understand what influences vaccination decisions.
This study looks at why some pregnant women might be unsure about getting vaccines. It aims to understand their concerns so that doctors and nurses can better support them.
This study tests if media materials can help parents or caregivers feel less anxious about childhood vaccines and increase their child's vaccination rates. If you have a child who is not fully vaccinated, you may be able to join.
This study tests an online tool to help people in Southeast Asia feel more confident about vaccines. If you live in Brunei, Indonesia, Malaysia, or Singapore and watch social media in Malay or Indonesian every day, you may be able to join.
This trial asks healthcare workers and adults about their views on getting vaccinated when they have a fever. It aims to understand what people think and do, to help improve vaccination practices.
This study looks at how well the VLA1553 vaccine prevents chikungunya disease in parts of Brazil where the vaccine is being offered as part of a pilot program. If you live in one of those areas and have had symptoms that might be chikungunya, this study will use your health records and blood tests to check how effective the vaccine is.
Hear when a new Vaccine Hesitancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.